J&J Vision extends cataracts land-grab with U.S., Canada approvals for vision-correcting intraocular lenses

Johnson & Johnson continued a string of recent approvals aimed at patients with cataracts, with the latest bringing its newer-generation intraocular lenses to U.S. and Canadian shores.

The company won FDA approval for its vision-correcting Tecnis Synergy and Tecnis Synergy Toric II lenses, with the latter also being cleared by Health Canada. The implanted lenses are designed to replace clouded or impaired lenses while also treating farsightedness, allowing clarity across a range of distances and lighting conditions.